1. Home
  2. TENX vs MOB Comparison

TENX vs MOB Comparison

Compare TENX & MOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

BUY

Current Price

$1.48

Market Cap

74.1M

Sector

Health Care

ML Signal

BUY

Logo Mobilicom Limited

MOB

Mobilicom Limited

BUY

Current Price

$3.12

Market Cap

73.7M

Sector

Real Estate

ML Signal

BUY

Company Overview

Basic Information
Metric
TENX
MOB
Founded
1967
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
74.1M
73.7M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
TENX
MOB
Price
$1.48
$3.12
Analyst Decision
Buy
Strong Buy
Analyst Count
10
2
Target Price
★ $12.56
$11.00
AVG Volume (30 Days)
★ 2.2M
113.6K
Earning Date
11-11-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$76.34
Revenue Next Year
N/A
$109.65
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.31
$2.77
52 Week High
$19.40
$9.78

Technical Indicators

Market Signals
Indicator
TENX
MOB
Relative Strength Index (RSI) 28.26 25.30
Support Level $1.31 N/A
Resistance Level $2.00 $5.54
Average True Range (ATR) 0.11 0.26
MACD 0.07 -0.10
Stochastic Oscillator 18.75 17.54

Price Performance

Historical Comparison
TENX
MOB

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About MOB Mobilicom Limited

Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.

Share on Social Networks: